Clinical Trials List
2020-10-30 - 2025-07-28
Phase III
Recruiting2
ICD-10E11.351
Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema
ICD-10E11.359
Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema
ICD-9362.02
Proliferative diabetic retinopathy
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 李學宇 無
- 賴泓吉 無
- 劉沛綱 無
- Yo-Chen Chang 無
- 林憲忠 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
11 participants
-
Global
706 participants
